From shedding pounds and treating sleep apnea to lowering the risk of heart attacks, GLP-1s have rapidly evolved beyond their original purpose of treating Type 2 diabetes.
Drugs like Ozempic and Wegovy are now being studied for a growing list of possible benefits, with early research pointing to possible effects on substance use disorders, neurodegenerative diseases like Alzheimer’s and even cancer outcomes.
Now, social media users are claiming the blockbuster medications may have another surprising perk: easing symptoms of ADHD.
“I have noticed a huge improvement with my procrastination,” wrote one GLP-1 user with ADHD on a Reddit thread about the strange side effect. “I didn’t even realize it until I noticed that things were getting done. Like … who did that? I did!”
“I started [Ozempic] about a week ago and I have noticed an increase in energy and focus,” commented another. “I feel as though a fog has lifted in my brain and [I’m] more motivated to do life than I have ever been.”
“I’m on Week 2 and it’s insane how clear I am,” chimed in a third. “I got into a discussion with my husband and normally I’d have fogged over or missed half my thoughts. I was clear and as sharp as a razor blade.”
ADHD — or attention-deficit/hyperactivity disorder — affects roughly 15.5 million American adults and an estimated 7 million children. It’s marked by persistent inattention, hyperactivity and impulsive behaviors that can disrupt daily life, relationships and work.
Treatment typically involves behavioral therapy, medication or a combination of both to improve focus, emotional regulation and impulse control — but some patients taking GLP-1s say they’re experiencing improvements they never achieved with traditional ADHD drugs.
“I have pretty severe ADHD, on meds for about 35 years. Some of them work decently, others don’t,” a Reddit user wrote. “One day after I started taking Ozempic, I started feeling like a superhero at work. My productivity is through the roof. No other medication has ever done this much for my ADHD.”
“I have seen a number of patients that have reported feeling better in terms of their ADHD symptoms when they went on GLP-1s.”
Dr. Lenard Adler
“I’ve taken Adderall for years but do not feel like it’s as effective as it was before I was taking [GLP-1s],’ another noted. “I have been procrastinating way less and not being as impulsive shopping-wise as I normally am.”
In clinical practice, Dr. Lenard Adler, director of the Adult ADHD Program at NYU Langone Health, said he’s been hearing similar accounts from his own patients.
“There is no large database here,” Adler, a psychiatrist, told The Post. “But I follow a couple hundred adults with ADHD, and anecdotally, I have seen a number of patients that have reported feeling better in terms of their ADHD symptoms when they went on GLP-1s.”
The most popular drugs in the GLP-1 receptor agonist category use either semaglutide, the active ingredient in Ozempic and Wegovy, or tirzepatide, which powers Mounjaro and Zepbound.
Adler said as many as 10% of the ADHD patients he treats are currently taking GLP-1s. Of those, he estimates roughly half have reported some improvement in their symptoms.
“It’s a small number, but it’s notable,” he said.
Scientists still don’t know whether the drugs directly improve ADHD symptoms. Currently, there are no active clinical trials specifically testing GLP-1 medications as a treatment for the disorder, according to ClinicalTrials.gov.
Still, Adler believes there are several plausible explanations for what patients are reporting.
“The preclinical work done with the GLP-1s shows that they seem to affect the areas in the brain that are involved in reward,” he explained. “So the thinking is that it may involve impulse control and motivation.”
“I just started taking tirzepatide and I have literally never felt so relaxed in my life.”
A GLP-1 user with ADHD
Because of differences in dopamine pathways, motivation for the ADHD brain is often driven more by what feels stimulating or rewarding than by what simply needs to get done. As a result, even important tasks can feel impossible to begin or complete.
“My biggest problem with ADHD is I am the biggest procrastinator,” a Reddit user wrote. “But with Ozempic, I get everything started and actually finish it.”
The same reward pathways are also linked to impulsivity, another hallmark ADHD trait. People with the disorder often struggle to resist behaviors that deliver a quick dopamine hit, but some patients say GLP-1s appear to be helping curb those urges.
“I’m considering going off my Adderall,” one Reddit user wrote. “I’ve been able to stop binge eating … I haven’t been impulse shopping … I also don’t pick at my skin. It’s amazing to me.”
But Adler said that the reported benefits may not stem from the drugs alone. GLP-1 users typically lose between 15% and 25% of their body weight over the course of a year, and he said the improvements some patients notice could be tied, at least in part, to the weight loss itself.
“One thing that we don’t know, and it’s an area that we’d like to investigate, is whether it’s the weight loss that’s leading to increased availability or their ADHD medicines,” Adler said.
“We also know that lifestyle issues affect ADHD symptoms, and if you lose weight and are able to become more active, you may be able to cope better with your symptoms.”
Whatever the reason, many patients say the drugs have quieted their mental chaos, bringing sharper focus, better self-control and a sense of calm that had previously felt out of reach.
“I’ve been on the highest dose of semaglutide for a bit over 2 months and I finally feel what I cannot put into words,” one wrote on Reddit. “Relief. Contentment. Peace.”
“I just started taking tirzepatide and I have literally never felt so relaxed in my life,” remarked another.
For Adler, stories like these underscore why the phenomenon deserves further study.
“I think it’s an area that really does merit further research,” he said. “We have patients that are on these medicines, and we need to better understand the potential effects of GLP-1s on ADHD symptoms directly — and potential side effects.”
Until scientists have more answers, Adler urged patients not to take matters into their own hands.
“If patients are thinking about going on GLP-1s and they have ADHD, they need to talk to both their medical doctors and the clinician prescribing their ADHD meds, so that everybody’s aware and coordinating their care,” he stressed.
